Stay updated on Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial

Sign up to get notified when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays the study record for a completed Phase 3b trial of sofosbuvir and ribavirin, including eligibility criteria, treatment arms, outcomes, locations, and publications, instead of an error page.
    Difference
    57%
    Check dated 2026-11-07T13:27:34.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T13:57:01.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition from using “artificial intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T17:30:46.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T17:07:15.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T17:59:36.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the usual study record content and navigation and blocking access to the study details. The surrounding site chrome remains visible, but the main content is inaccessible.
    Difference
    17%
    Check dated 2026-09-19T19:13:21.000Z thumbnail image

Stay in the know with updates to Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.